Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial

Journal:

Nature Communications

Published:

2025-08-01

DOI:

10.1038/s41467-025-62249-0

Affiliations:

6

Authors:

21

Go to article

Institutions	Authors	Share
The Institute of Cancer Research (ICR), United Kingdom (UK)	9.500000	0.45
The Royal Marsden NHS Foundation Trust, United Kingdom (UK)	6.500000	0.31
AstraZeneca Cambridge, United Kingdom (UK)	3.000000	0.14
The Christie NHS Foundation Trust, United Kingdom (UK)	1.000000	0.05
UCL, United Kingdom (UK)	0.500000	0.02
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK)	0.500000	0.02

Interested in Oncology and Carcinogenesis?